Skip to content

Clinical trials

Phase 2 Leukemia, Lymphocytic, Chronic, B-Cell trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Lymphocytic, Chronic, B-Cell Phase: Phase 2 Country / region: United States Clear all

540 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200022
200115
200214
200314
200429
200528
200624
200721
200829
200914
201034
201123
201218
201313
201414
201516
201616
201719
201813
201911
202017
20219
20229
20239
20247
202510
202616

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed326
Terminated94
Active, not recruiting43
Recruiting39
Withdrawn21
Unknown status10
Not yet recruiting7

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center60
Fred Hutchinson Cancer Center41
National Cancer Institute (NCI)35
Memorial Sloan Kettering Cancer Center19
Mayo Clinic18
City of Hope Medical Center16
National Heart, Lung, and Blood Institute (NHLBI)16
Masonic Cancer Center, University of Minnesota14
H. Lee Moffitt Cancer Center and Research Institute12
Alliance for Clinical Trials in Oncology10

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Lymphocytic, Chronic, B-Cell540
Lymphoma, Follicular192
Lymphoma, Non-Hodgkin191
Leukemia184
Lymphoma, B-Cell, Marginal Zone171
Precursor Cell Lymphoblastic Leukemia-Lymphoma168
Lymphoma164
Lymphoma, Mantle-Cell160
Lymphoma, Large B-Cell, Diffuse145
Hodgkin Disease138

Trials

Showing 1 to 25 of 540. Each trial links to its page on Pharma Observatory.

440 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.